Relmada Therapeutics director buys $33,280 in company stock

Tomas Kauer - Moderator

Sep 12, 2024 - 06:00

Relmada Therapeutics director buys $33,280 in company stock

Tags:

Previous Article

Relmada Therapeutics CFO buys $149,700 in company stock

Cyanotech executive Michael A. Davis buys shares worth $8,350

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

Permanent wants to permanently change where commercial buyers get their food

Permanent wants to permanently change where commercial ...

Tomas Kauer - Mode... Oct 3, 2024

Era Ventures raises $88M first fund for transforming the ‘built’ environment

Era Ventures raises $88M first fund for transforming th...

Tomas Kauer - Mode... Sep 19, 2024

TikTok asks Supreme Court for a lifeline as sell-or-ban deadline approaches

TikTok asks Supreme Court for a lifeline as sell-or-ban...

Tomas Kauer - Mode... Dec 17, 2024